The FDA, along with CDC, state and local agencies, is investigating a multistate outbreak of E. coli O157:H7 illnesses likely linked to romaine lettuce grown in California this fall.
Ottogi America, Inc. of Gardena, California announced today it is recalling 1lb 5.16ounce of Jin Ramen Mild 5pk. (Best Before Aug. 19th 2019) and Jin Ramen Spicy 5pk. (Best Before Aug. 20th 2019) due to undeclared egg as an ingredient on the packages.
Food Safety Strategies was recently able to interview FARE (Food Allergy Research & Education) CEO Lisa Gable on the FDA's new statement on consideration for sesame allergies.
165368 C. Corporation, doing business as Long Phung Food Products, a Houston, Texas establishment, is recalling an undetermined amount of ready-to-eat pork products that may be adulterated with Listeria monocytogenes, the U.S. Department of Agriculture’s Food Safety and Inspection Service (FSIS) announced.
The CDC is advising that U.S. consumers not eat any romaine lettuce, and retailers and restaurants not serve or sell any, until more is learned about the outbreak. This investigation is ongoing and the advice will be updated as more information is available.
Many members of the traditional food and beverage industry—in both manufacturing and from the supply chain—have been reluctant to enter the market due to incongruences related to federal vs. state legal status, the unfamiliarity of the territory, restrictive banking options for legal cannabis businesses, limits imposed on advertising and social media, and other hurdles.
Deleite Foods Enterprises, Inc., a Salt Lake City, Utah establishment, is recalling approximately 11,000 pounds of marinated raw poultry products due to misbranding and undeclared allergens, the U.S. Department of Agriculture’s Food Safety and Inspection Service (FSIS) announced today.
The Quaker Oats Company, a subsidiary of PepsiCo, Inc., has announced a voluntary recall of a small quantity of Cap’n Crunch’s Peanut Butter Crunch cereal due to the potential presence of Salmonella.
Arcview Market Research and BDS Analytics predict that combined medical and recreational legal cannabis sales in the U.S. will top $11 billion in 2018. And according to the 2017 "Marijuana Business Factbook" from Marijuana Business Daily, by 2021 U.S. sales are anticipated to top $17 billion.